Skip to main content
Sign In
 

Robert D. Davies, MD

Associate Professor


Contact Info:
 
Clinical/Research Interests:
Dr. Davies is interested in mood and anxiety disorders, non-traditional interventions for adolescent substance abuse (including martial arts), as well as resident and medical student education.


 University of Colorado, Boulder DB 1985 (with distinction)

UC School of Medicine MD 1989

Davies, R. D., Dubovsky, S. L., Gabbert, S., Chapman, M. (2000). Treatment resistance in anxiety disorders. Bulletin of the Menninger Clinic, 64(3A), A22-A36.

Davies, R. D., Winter, L. (2001). Generalized Anxiety Disorder. In J. Jacobson, A. Jacobson (Eds.), Psychiatric Secrets, Second Edition. Philadelphia, PA: Hanley and Belfus Inc.

Davies, R. D. (2001). Social Phobias and Specific Phobias. In J. Jacobson, A. Jacobson (Eds.), Psychiatric Secrets, Second Edition. Philadelphia, PA: Hanley and Belfus Inc.

Davies, R. D. (2001). Panic Attacks and Panic Disorder. In J. Jacobson, A. Jacobson (Eds.), Psychiatric Secrets, Second Edition. Philadelphia, PA: Hanley and Belfus Inc.

Davies, R. D., Gabbert, S. L., Riggs, P. D. (2001). Anxiety disorders in neurologic illness. Current Treatment Options in Neurology3(4), 333-346.

Dubovsky, S., Davies, R., Dubovsky, A. (2002). Mood disorders. In R. E. Hales, S. C. Yudofsky, J. A. Talbott (Eds.), American Psychiatric Press Textbook of Psychiatry, Fourth Edition. Washington, DC: American Psychiatric Press.

Riggs, P. D., Davies, R. D. (2002). A Clinical Approach to Integrating Treatment for Adolescent Depression and Substance Abuse. Journal of the American Academy of Child and Adolescent Psychiatry41(10), 1253-1255.

Davies, R. D., Chapman, M. M., Hall, S. K., Mikulich, S. K., Riggs, P. D. (2002). Correlates of social phobia in depressed adolescents with conduct disorder and substance dependence. Drug and Alcohol Dependence66, S41.

Riggs, P. D., Lohman, M., Davies, R., Klein, C., Chapman, M., Laudenslager, M., Mikulich-Gilbertson, S. K., Libby, A., Orton, H., Stover, S., Thurstone, C. (2005). Randomized Controlled Trial of Fluoxetine vs. Placebo + CBT in Depressed Adolescents with Substance Use Disorders. Poster presentation: 67th Annual Meeting of the College on Problems of Drug Dependence, Orlando, Florida.

Davies, R., Riggs, P., Chapman, M., Orton, H., Mikulich-Gilbertson, S., Hall, S. (2005). Social Phobia in Depressed, Substance Dependent Adolescents. Poster presentation: American Academy of Child & Adolescent Psychiatry 52nd Annual Meeting, Toronto, Canada.

Davies, R. D., Riggs, P. D. (2007). Integrated treatment of substance use disorders and co-occurring psychiatric disorders in adolescents. In E. Gilvarry & P. McArdle (Eds.), Alcohol, Drugs, and Young People: Clinical Approaches. (pp. 225-234). London: MacKeith Press.

Riggs, P. D., Mikulich-Gilbertson, S. K., Davies, R. D., Lohman, M., Klein, C., Stover, S. K. (2007). A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Archives of Pediatric and Adolescent Medicine161(11), 1-9.

Davies, R., Mikulich-Gilbertson, S., Riggs, P. D., Stover, S., Riley, L., Madani, F., Thurstone, C. (2007). Traditional Martial Arts in the Treatment of Substance Abusing Youth. Poster presentation: 69th Annual Meeting of the College on Problems of Drug Dependence, Quebec City, Canada.

Davies, R., Kayser, A., Klein, C., Mikulich-Gilbertson, S., Stover, S., Madani, F., Madani, C., Schneider, A., Riggs, P. (2007). Martial Arts as Early Intervention for Teen Drug Abuse: Behavioral Therapy Development. Poster presentation: American Academy of Child and Adolescent Psychiatry 54th Annual Meeting, Boston, Massachusetts.

Davies, R., Mikulich-Gilbertson, S., Stover, S., Riggs, P. (2008). Use of Quantitative THC/creatinine Ratio to Refine Urinalysis Results in Teen Drug Abuse Studies. Poster presentation: 70th Annual Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.

Davies, R. (2009). Review of Adolescent Substance Abuse: Psychiatric Co-Morbidity and High Risk Behaviors by Yifrah Kaminer and Oscar G. Bukstein. American Journal of Psychiatry166, 117.

Davies, R. (2009). Tolerability, Safety, Abuse & Diversion in Multisite Trial of OROS-MPH vs Placebo in Adolescents with ADHD and SUD. Symposium: American Academy of Child & Adolescent Psychiatry 56th Annual Meeting, Honolulu, Hawaii.​​

GRANTS AND CONTRACTS

5/1/2006-4/30/2010 R01 DA018679 (Davies, PI) NIH/NIDA Martial Arts as Early Intervention for Teen Drug Abuse   

This is a Stage 1A/1B behavioral therapies development grant with the primary aims of developing a manualized early intervention for adolescent substance abuse (based on traditional martial arts) and then conducting a pilot study in order to estimate the effect size of the intervention and provide information for estimating power for a larger randomized controlled trial. Role: Principal Investigator.

8/15/2008 - 6/30/2013 R01 DA022284 (Riggs, PI) NIH/NIDA Bupropion for ADHD in Adolescents with Substance Use Disorders

Randomized, placebo-controlled trial of bupropion + cognitive-behavioral therapy (CBT) in adolescents with ADHD and nicotine and cannabis use. Specific aims are to evaluate the safety and efficacy of this low abuse potential medication on ADHD, nicotine dependence, and cannabis use disorders in adolescents receiving concurrent outpatient substance treatment (CBT). Role: Co-Investigator

Competed Research Support (past 3 years)

9/01/2005-8/31/2009 U10 DA013732 (Somoza PI) NIH/NIDA Clinical Trials Network, Ohio Valley Node                                               

Dr. Davies’ involvement with the Clinical Trials Network continues via a subaward arrangement with the

University of Cincinnati/ Ohio Valley Node. Dr. Davies serves as Co-Lead Investigator for the protocol: “A

Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit

supported under this subaward. Role: Medical Co-Lead Investigator

9/30/2000-7/31/2007 R01 DA13176 (Riggs PI) NIH/NIDA Substance Dependent Teens: Impact of Treating Depression

Completed five-year placebo-controlled clinical trial assessing the impact of treatment of depression with fluoxetine + cognitive behavioral therapy (CBT) in adolescents with substance use disorders. This psychosocial treatment for substance use disorders was manualized and empirically supported.  Two administrative supplements were awarded by NIDA under the parent grant: 1) NIDA 3R01DA13176-02S1, investigated change in biomarkers (serotonin, cortisol, DHEA, testosterone) with treatment, and 2) NIDA 3R01DA13176-03S1, investigated the effect of a brief CBT interview on reducing HIV risk behaviors. Role: Co-Investigator